All Articles

BlackLine's record Q2 profits are fueled by its AI platform, but CEO Owen Ryan warns of 'noisy deal timing' as smarter customers lengthen sales cycles.

With a fortified balance sheet and a strategic pivot, OnKure Therapeutics is betting that precision and selectivity will conquer a competitive drug market.

While the broader pool industry treads water, Latham Group reports surging sales and raises its outlook. The secret? A strategic pivot to fiberglass pools and a targeted push into the Sun Belt.

LeMaitre reports double-digit growth driven by its Artegraft product, but misses analyst estimates. A deep dive into its global strategy and financial health.

Workiva crushes Q2 estimates, hitting profit targets a year early. A deep dive into how its ‘agentic-first’ AI is redefining the blueprint for success.

Alphatec's stellar financials are just the surface. We go inside the OR to see how its integrated procedural approach is winning surgeons and changing outcomes.

Nextdoor achieved its strongest financial quarter ever, swinging to a positive Adjusted EBITDA. We analyze the disciplined strategy that turned the corner.

CACC posts a huge profit jump, crediting its AI strategy for new efficiencies. But a closer look at loan data reveals challenges in a tough market.

The finalized KPS Global-Everidge partnership creates a dominant force in the US cold storage market, promising logistical synergies and customer-focused innovation.

Bed Bath & Beyond is dead. In its place rises Neighborhood Intelligence, a tech-driven titan aiming to conquer the entire homeownership lifecycle.

Amid a biotech funding revival, Twist's upsized $300M deal signals a bold move to expand its synthetic biology platform, fueling a high-stakes investor debate.

As Canada's Top 25 Immigrant Awards laud individual triumphs, they also highlight a crucial national dialogue on immigration, policy, and economic reality.

SLR Investment reports a covered dividend but a declining NAV. A deep dive into its strategic shift to asset-based lending amid market uncertainty.

Macnica's majority stake in Orangeleaf Consulting isn't just a deal. It's a strategic bet on Malaysian agility to solve Japan's deep-rooted DX crisis.

Ariel Construction's transparent, single-contract model earns 1,000+ top reviews. Its next move? A strategic vertical leap into roofing, starting in Dallas.

Facing revenue headwinds from currency shifts and regulatory hurdles, China's Jin Medical doubles down on R&D and operational efficiency. A look inside their strategy.

As RideNow Group preps its Q2 report, all eyes are on its unique pre-owned vehicle strategy. Can this digital-first approach rev up growth?

Emerson appoints Rudy Sengupta as its new Chief Technology and AI Officer, a strategic move signaling a major acceleration of its plan to dominate industrial AI.

Xtant Medical's leadership heads to a top investor conference, aiming to validate its orthobiologics strategy and prove its path from prototype to profit.

Revolve Group boasts a stellar quarter with soaring sales and customer growth, but a one-time tariff refund artificially inflates profits, masking rising costs and negative cash flow.